Pulmonary hypertension (PH) is a hemodynamic and pathophysiologic state that can be
found in multiple conditions with associated symptoms of dyspnea, decreased exercise …

Pulmonary hypertension may develop as a disease process specific to pulmonary arteries
with no identifiable cause or may occur in relation to other cardiopulmonary and systemic …

Pulmonary arterial hypertension (PAH), the first category of pulmonary hypertension, is a
chronic and progressive disorder characterised by angioproliferative vasculopathy in the …

Pulmonary hypertension (PH) and its severe subtype pulmonary arterial hypertension (PAH)
encompass a set of multifactorial diseases defined by sustained elevation of pulmonary …

Pulmonary hypertension (PHTN) is a rare and devastating disease characterized by
progressive increases in pulmonary arterial pressure and pulmonary vascular resistance …

Pulmonary hypertension (PH) is a progressive and often fatal illness presenting with
nonspecific symptoms of dyspnea, lower extremity edema, and exercise intolerance …

Pulmonary arterial hypertension (PAH) is a panvasculopathy that affects the distal
pulmonary arteries and leads to restricted blood flow. This increased afterload leads to …

Pulmonary hypertension is a fatal disease of multiple etiologies that is estimated to affect
over 100 million people worldwide. The disease is defined hemodynamically as a mean …

Pulmonary artery hypertension (PAH) refers to several subgroups of disease in which the
mean pulmonary artery pressure (mPAP) is elevated to more than 25 mm Hg, pulmonary …

Pulmonary hypertension (PH) is a rare heterogenous disease characterized by elevated
blood pressure in the lungs. Patients with PH require careful evaluation and management at …